SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Dr. Nancy Simonian on Q3 2018 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS)
Q3 2018 Results Earnings Conference Call
November 01, 2018 07:30 AM ET
Executives
Naomi Aoki - VP, Corporate Communications and IR
Dr. Nancy Simonian - CEO
Dr. David Roth - Chief Medical Officer
Dr. Eric Olson - Chief Scientific Officer
Joe Ferra - CFO
Analysts
Phil Nadeau - Cowen and Company
Ted Tenthoff - Piper Jaffray
Konstantinos Aprilakis - JMP Securities
Presentation
Operator
Good morning, and welcome to the Syros Pharmaceuticals Third Quarter 2018 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media